Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Benefits and Harms of CT Screening for Lung Cancer
1.245
Zitationen
15
Autoren
2012
Jahr
Abstract
Low-dose computed tomography screening may benefit individuals at an increased risk for lung cancer, but uncertainty exists about the potential harms of screening and the generalizability of results.
Ähnliche Arbeiten
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
2011 · 10.808 Zit.
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
2016 · 9.927 Zit.
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 · 8.207 Zit.
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
2015 · 6.481 Zit.
Deep Convolutional Neural Networks for Computer-Aided Detection: CNN Architectures, Dataset Characteristics and Transfer Learning
2016 · 5.725 Zit.
Autoren
Institutionen
- Memorial Sloan Kettering Cancer Center(US)
- SUNY Downstate Health Sciences University(US)
- American Society of Clinical Oncology(US)
- The University of Texas MD Anderson Cancer Center(US)
- Emory University(US)
- Colorado School of Public Health(US)
- Washington University in St. Louis(US)
- Kaiser Permanente(US)
- University of Colorado Denver(US)
- Baylor College of Medicine(US)
- University of California, San Francisco(US)
- University of Washington(US)
- American Board of Internal Medicine(US)
- Yale University(US)